Jian Wang | Vascular regeneration | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Mr. Jian Wang | Vascular regeneration | Best Researcher Award

Yunnan University of Chinese Medicine | China

Author Profile:

Scopus

🌟 JIAN WANG: PIONEER IN TRADITIONAL CHINESE MEDICINE FOR NEUROLOGICAL HEALTH

🎓 EARLY ACADEMIC PURSUITS

Jian Wang embarked on his academic journey with a profound interest in the integration of Traditional Chinese Medicine (TCM) and modern neurological science. From the outset of his career, he demonstrated exceptional dedication to understanding the molecular and clinical pathways underlying neurological disorders. His educational background, though not explicitly detailed, reflects extensive scholarly preparation, equipping him to contribute significantly to both basic and clinical research in the realm of stroke and cerebral ischemia.

🧑‍⚕️ PROFESSIONAL ENDEAVORS

Jian Wang serves as a Discipline Leader and Technological Innovation Talent of Yunnan Province and is recognized as a Senior Talent in Traditional Chinese Medicine of Yunnan Province. He is currently affiliated with Yunnan University of Chinese Medicine, where he actively leads research teams, mentors young scientists, and advances the field of integrative neurology. His leadership roles underscore his commitment to elevating the scientific standing of Traditional Chinese Medicine both regionally and nationally.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON VASCULAR REGENERATION

Professor Wang's research is rooted in neuroprotection, stroke therapy, and inflammatory response modulation, using both experimental models and clinical applications of TCM. His focus spans:

  • Cuproptosis mechanisms in stroke pathogenesis 🧪

  • Electroacupuncture's effects on inflammation and neural regeneration ⚡

  • Network pharmacology and molecular docking for TCM compounds 🌿

  • Gut microbiota's role in osteoarthritis and brain health 🦠

  • Innovative TCM formulations for cognitive impairment and nephritis 🧠

Through these endeavors, he bridges modern biomedical science with classical Chinese therapeutics, enhancing treatment modalities for cerebral ischemia, stroke, and neuroinflammatory disorders.

📚 ACADEMIC CITES AND PUBLICATIONS

Jian Wang has co-authored numerous high-impact publications in esteemed journals such as Frontiers in Molecular Neuroscience, Neuroreport, and the American Journal of Chinese Medicine. Key articles include:

  • Studies on cuproptosis in stroke (Front Mol Neurosci, 2024)

  • Mechanistic insights on electroacupuncture (Neuroreport, 2025)

  • Gut microbiota links to osteoarthritis (Am J Chin Med, 2025)

  • TCM compound analyses using network pharmacology (Chem Biodivers, 2025)

These publications reflect his role as a thought leader in the evolving dialogue between Eastern and Western medical sciences.

🔍 RESEARCH PROJECTS AND SCIENTIFIC LEADERSHIP

Jian Wang has been entrusted with several prestigious research grants, including:

  • National Natural Science Foundation of China (NSFC) projects exploring electroacupuncture's role in nerve regeneration.

  • Yunnan Provincial Science and Technology Department initiatives focusing on inflammatory pathways such as NF-κB, NLRP3, and NAMPT in stroke models.

As a Principal Investigator, his projects not only advance basic science but also hold direct clinical implications for stroke rehabilitation and neurological recovery.

🌏 IMPACT AND INFLUENCE

Beyond his individual research achievements, Jian Wang plays a pivotal role in mentoring emerging researchers in Traditional Chinese Medicine. His work influences clinical practices in Yunnan Province and contributes to international scientific dialogues on stroke management, neuroinflammation, and integrative medicine.

His studies on electroacupuncture, paeony glucosides, and Ligusticum wallichii-Borneol combinations are referenced by scholars exploring alternative therapeutic strategies for stroke, vasculitis nephritis, and neurodegeneration.

🚀 LEGACY AND FUTURE CONTRIBUTIONS

Jian Wang's enduring legacy lies in his pioneering integration of TCM and neuroscience, setting a standard for multidisciplinary approaches to brain health. Looking ahead, his ongoing projects aim to further elucidate:

  • The regenerative pathways triggered by TCM therapies,

  • Novel targets for post-stroke neurorehabilitation,

  • Expanded clinical trials validating acupuncture and herbal treatments for neurological diseases.

His vision encompasses making Traditional Chinese Medicine a globally recognized and scientifically validated option for treating complex neurological conditions.

📑NOTABLE PUBLICATIONS

"Gut Microbiota and Osteoarthritis: From Pathogenesis to Novel Therapeutic Opportunities"

Authors: Xi Y, Wang Z, Wei Y, Xiao N, Duan L, Zhao T, Zhang X, Zhang L, Wang J, Li Z, Qin D
Journal: American Journal of Chinese Medicine
Year: 2025

"Cuproptosis in stroke: focusing on pathogenesis and treatment"

Authors: Xing L, Wang Z, Hao Z, Pan P, Yang A, Wang J
Journal: Frontiers in Molecular Neuroscience
Year: 2024

 

Yajie Liu | Cardiac Imaging | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Yajie Liu | Cardiac Imaging | Best Researcher Award

Peking University Shenzhen Hospital | China

Author Profile:

Scopus

Orcid

🌟Prof. Dr. Yajie Liu – A Pioneer in Radiation Oncology & Cancer Research Excellence

🎓 EARLY ACADEMIC PURSUITS

Dr. Yajie Liu began her medical journey with a Bachelor of Medicine (1985–1990) from Norman Bethune University of Medical Sciences. Driven by a deep interest in oncology, she completed her Master's degree in Oncology (1993–1996) from Harbin Medical University, followed by a prestigious Ph.D. in Oncology (1998–2001) at the Peking Union Medical College.

To expand her global medical perspective, she completed a Visiting Scholar Fellowship in Radiation Oncology at Chonnam National University Hospital in South Korea in 2010.

🏥 PROFESSIONAL ENDEAVORS

Dr. Liu's medical career spans over three decades of dedicated clinical service and leadership:

  • 1990–1992: Resident Physician, ENT, First Workers' Hospital of Liaohe Petroleum Exploration Bureau

  • 1992–1998: Resident & Attending Physician, Radiation Oncology, The Third Affiliated Hospital of Harbin Medical University

  • 2001–2017: Progressed from Attending to Chief Physician and Deputy Director at Shenzhen People’s Hospital

  • 2017–Present: Chief Physician and Director, Department of Radiation Oncology, Peking University Shenzhen Hospital

Her ascent to leadership reflects a consistent trajectory of clinical excellence and patient-centered care in oncology.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC IMAGING

Dr. Liu has led and co-led numerous research projects focused on:

  • Radiosensitization in Cancer Therapy

  • Hyperthermia and Serum Biomarkers

  • Radiation-Induced Brain Injury

  • Gene Assays for Breast Cancer Prognosis

  • Advanced Radiotherapy Strategies for Rectal and Colorectal Cancer

She has actively participated in national-level research, contributing to the Ministry of Science & Technology's high-impact projects on biomarkers and innovative radiotherapy techniques.

💡 RESEARCH FUNDING & PROJECT LEADERSHIP

As Principal Investigator (PI):

  • Shenzhen Science & Technology Bureau (4 Projects)

  • Shenzhen Health Commission (1 Project)

  • International Collaboration Grant (¥500K)

These funded projects demonstrate her innovative approach in blending clinical insight with technological advancement, especially in plasma therapy and hypoxic tumor sensitization.

🌐 PROFESSIONAL LEADERSHIP & ACADEMIC SERVICE

Dr. Liu holds key roles in multiple national and regional medical bodies:

  • Standing Committee Member, CRTOG

  • Committee Member, Radiotherapy Branch, Chinese Medical Doctor Association

  • Vice Chair, Lung Cancer Committee, Guangdong Women Doctors’ Association

  • Director, Radiotherapy Branch, Shenzhen Anti-Cancer Association

  • Council Member, Jiusan Society Shenzhen Chapter

Her positions reflect widespread recognition of her expertise and leadership in oncology.

📚 ACADEMIC CITES & COLLABORATIONS

While specific citation metrics are not provided here, Dr. Liu’s work on biomarkers, 21-gene assays, radiation injury, and colorectal cancer radiosensitization has contributed to national and international collaborations, significantly enriching the literature in radiation oncology.

🌍 IMPACT AND INFLUENCE

Dr. Liu's multidisciplinary research has influenced clinical protocols, improved patient outcomes, and inspired young oncologists across China. Her work on low-temperature plasma in radiosensitization reflects her commitment to cutting-edge translational oncology.

🔮 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Yajie Liu's legacy is marked by:

  • Pioneering radiotherapy techniques

  • Mentoring future oncology leaders

  • Driving forward international research collaborations

Her future direction is expected to focus on precision oncology, AI-guided radiotherapy planning, and expanding patient-centered cancer care models.

📑 NOTABLE PUBLICATIONS

"Supplementing sialic acid analogs overcomes radiotherapy resistance in triple-negative breast cancer by exacerbating ER stress"

Authors: M Yang, D Shi, J Lyu, Y Pan, Y Lyv, X Chen, Y Ouyang, Y Liu, Y Li, L Song
Journal: Redox Biology
Year: 2025

"X-ray-activated nanoscintillators integrated with tumor-associated neutrophils polarization for improved radiotherapy in metastatic colorectal cancer"

Authors: H Li, J Zeng, Q You, M Zhang, Y Shi, X Yang, W Gu, Y Liu, N Hu, Y Wang, X Chen, J Mu
Journal: Biomaterials
Year: 2025

Yusheng Liu | Interventional Cardiology | Best Researcher Award 

Published on by Cardiology and Cardiovascular Medicine

Prof. Yusheng Liu | Interventional Cardiology | Best Researcher Award

The Second Hospital of Shandong University | China

Author Profile:

Scopus

🩺 PROF. YUSHENG LIU – A PIONEER IN HEART FAILURE & ECHOCARDIOGRAPHY

🎓 EARLY ACADEMIC PURSUITS

Prof. Yusheng Liu began his illustrious academic journey in Clinical Medicine at Taishan Medical School (now The First Medical University of Shandong), earning his Bachelor’s degree (1995–2000). His quest for deeper knowledge led him to pursue a Master’s degree in Internal Medicine with a focus on Cardiovascular Disease at Shandong University School of Medicine (2004–2007), followed by an M.D. in Cardiovascular Medicine (2010–2013) from the same institution.

👨‍⚕️ PROFESSIONAL ENDEAVORS

Since July 2000, Prof. Liu has served at the Second Hospital of Shandong University, currently holding the title of Deputy Chief Physician of Cardiovascular Medicine, Associate Professor, and Doctoral Supervisor. He also leads the Cardiac Care Unit (CCU) and plays a pivotal role in guiding the next generation of clinicians as a Master’s tutor.

His career also extends into professional societies, where he holds several leadership roles, including:

  • Executive Director, China Ultrasonic Medical Engineering Society (Echocardiography Division)

  • Vice Chairman, Shandong Ultrasound in Medicine Engineering Institute

  • Youth Leader, Shandong Medical Health System

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON INTERVENTIONAL CARDIOLOGY

Prof. Liu has dedicated his research to heart failure, echocardiography, coronary artery disease, and atherosclerosis. He has:

  • Led or contributed to multiple National Key Projects such as 973, 863, and the National Natural Science Foundation

  • Chaired international collaborations like the Macau SAR Science & Technology Fund

  • Focused heavily on biomarker-based diagnostics, ventricular function in diabetes, and plaque stability in coronary syndromes

His projects have bridged clinical and basic science, contributing to real-world patient improvements and high-impact academic knowledge.

🏆 IMPACT AND INFLUENCE

Prof. Liu’s work has been nationally and internationally recognized:

  • Two-time winner of National Science and Technology Progress Award

  • Recipient of multiple provincial awards including 4 second-place and 6 third-place Science & Tech Awards

  • Frequent keynote speaker at conferences such as:

    • 24th Great Wall International Cardiology Conference

    • 12th National Echo Cardiac Conference

    • 2016 Pharmacology & Ethnopharmacology Conference, Chicago, USA

He is also involved in clinical ethics, oncology cardiology, heart rehabilitation, and hypertension professional committees.

📚 ACADEMIC CITATIONS AND MEMBERSHIPS

Prof. Liu is a proud member of:

  • American Society of Echocardiography (ASE)

  • China Ultrasound Medical Engineering Society (Permanent Member)

  • Various Shandong Medical Associations across cardiology, ethics, and disaster medicine

His publications and research are cited in numerous national and international cardiovascular journals and conferences, further amplifying his impact on the global stage.

🧪 SCIENTIFIC PROJECTS (SELECTED)

Some of the noteworthy research projects under his leadership include:

  1. Huatong-Guokang Medical Scientific Research Project – Ministry of Education (2023)

  2. Clinical Elite Scientist Programme (2018)

  3. National Key R&D Plan (2022YFC3502100)

  4. Lipoprotein-Associated Phospholipase A2 and Plaque Stability (2014)

  5. JNK Pathway and Atherosclerosis Mechanism (2013)

  6. DPP-4 Inhibitors and Ventricular Function in Diabetic Patients (2013)

🏅 AWARDS AND HONORS

Prof. Liu has received:

  • Lecture Honorary Certificate – Pharmacology & Ethnopharmacology 2016

  • Shandong Soft Science Excellence Award

  • Outstanding Teaching Certificate – Weifang University (2016)

  • Advanced Medical Worker Honor – Phoenix Media

  • Scholarships from Shandong University and affiliated hospitals

🌍 LEGACY AND FUTURE CONTRIBUTIONS

Prof. Yusheng Liu stands as a leading voice in the evolution of cardiovascular care in China and beyond. His multidisciplinary influence spans clinical excellence, scientific innovation, academic mentorship, and global collaboration.

In the years to come, his focus on integrating precision medicine, biomarkers, and advanced imaging will continue shaping the future of heart failure diagnostics, ultrasound cardiology, and clinical translational research. With a legacy rooted in innovation and education, he continues to inspire and uplift the cardiovascular medicine community.

📑 NOTABLE PUBLICATION

"Analysis of Platelet Morphological Parameters as Clinical Risk Stratification in Acute Coronary Syndrome"

Authors: Xuguang Zhang, Zhiwei Huang, Xin Wang, Han Hao, Dali Fan, Martin Cadeiras, Yusheng Liu
Journal: Catheterization and Cardiovascular Interventions
Year: 2025